HOUT-17. A PRELIMINARY DATA REPORT ON A PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA

ανά Bota, Daniela, Chung, Jinah, Carrillo, Jose, Kong, Xiao-Tang, Fu, Beverly, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil, Stathopoulos, Apostolos
Τόπος έκδοσης Neuro Oncol (2017)

ATIM-42. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: OS CORRELATIONS WITH INITIAL AND MAXIMUM CD4+T LYMPHOCYTE COUNT IN THE PERIPHERAL BL...

ανά Bota, Daniela, Taylor, Thomas, Xiao-Tang, Kong, Fu, Beverly, Alsharif, Mohamad, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil, Stathopoulos, Apostolos
Τόπος έκδοσης Neuro Oncol (2019)

ET-54 IMMUNOTHERAPY BASED ON TUMOR TRANSPLANT ANTIGEN RECOGNITION EMERGES AS A PROMISING STRATEGY FOR RECURRENT GLIOBLASTOMA MULTIFORME (GBM) PATIENTS

ανά Schijns, Virgil, Pretto, Chrystel, Devillers, Laurent, Pierre, Denis, Hofman, Florence, Kruse, Carol, Chen, Thomas, Oertel, Joachim, Hantos, Peter, Bota, Daniela, Stathopoulos, Apostolos
Έκδοση 2014

Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation

ανά Stathopoulos, Apostolis, Pretto, Chrystel, Devillers, Laurent, Pierre, Denis, Hofman, Florence M., Kruse, Carol, Jadus, Martin, Chen, Thomas C., Schijns, Virgil E.J.C.
Έκδοση 2012

Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report

ανά Bota, Daniela A, Alexandru-Abrams, Daniela, Pretto, Chrystel, Hofman, Florence M, Chen, Thomas C, Fu, Beverly, Carrillo, Jose A, Schijns, Virgil EJC, Stathopoulos, Apostolos
Τόπος έκδοσης Perm J (2015)

Exploring the Therapeutic Efficacy of Glioma Vaccines Based on Allo- and Syngeneic Antigens and Distinct Immunological Costimulation Activators

ανά Stathopoulos, Apostolos, Pretto, Chrystel, Devillers, Laurent, Pierre, Denis, Hofman, Florence M., Epstein, Alan L., Farghadani, Hooman, Kruse, Carol A., Jadus, Martin R., Chen, Thomas C., Schijns, Virgil E.J.C.
Έκδοση 2012

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4(+) T-lymphocyte counts

ανά Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-Tang, Fu, Beverly D, Hsu, Frank PK, Schönthal, Axel H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil EJC, Stathopoulos, Apostolos
Τόπος έκδοσης CNS Oncol (2018)

ATIM-28. PHASE 2 STUDY OF ERC1671 PLUS BEVACIZUMAB VS BEVACIZUMAB PLUS PLACEBO IN RECURRENT GBM INTERIM RESULTS AND CORRELATIONS WITH CD4+ T LYMPHOCYTE COUNTS

ανά Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-tang, Beverly Fu, Dan, Hsu, Frank P K, Schönthal, Alex H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil E J C, Stathopoulos, Apostolos
Τόπος έκδοσης Neuro Oncol (2018)

Therapeutic Immunization against Glioblastoma

ανά Schijns, Virgil E. J. C., Pretto, Chrystel, Strik, Anna M., Gloudemans-Rijkers, Rianne, Devillers, Laurent, Pierre, Denis, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A., Kong, Xiao-Tang, Fu, Beverly D., Hsu, Frank P. K., Hofman, Florence M., Chen, Thomas C., Zidovetzki, Raphael, Bota, Daniela A., Stathopoulos, Apostolos
Τόπος έκδοσης Int J Mol Sci (2018)